Neuroimmune Activation in Chronic Heart Failure

E-ISSN： 2212-3873|13|1|68-75

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.13, Iss.1, 2013-03, pp. : 68-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic administration of moxonidine suppresses sympathetic activation in a rat heart failure model

By Van Kerckhoven R. van Veen T.A.B. Boomsma F. Saxena P.R. Schoemaker R.G.

European Journal of Pharmacology, Vol. 397, Iss. 1, 2000-05 ,pp. : 113-120

Elsevier

Access to resources Recommend Favorite

Valsartan: In Chronic Heart Failure

By Wellington K. Goa K.L.

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 4, 2002-01 ,pp. : 267-274

Adis International

Access to resources Recommend Favorite

Pharmacologic Therapy of Chronic Heart Failure

By Hamad Eman Mather Paul J. Srinivasan Siva Rubin Sharon Whellan David J. Feldman Arthur M.

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 4, 2007-01 ,pp. : 235-248

Adis International

Access to resources Recommend Favorite

Carvedilol in the treatment of chronic heart failure

By Moe G.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 5, 2001-05 ,pp. : 831-843

Informa Healthcare

Access to resources Recommend Favorite

Animal Models of Chronic Heart Failure

By Muders F. Elsner D.

Pharmacological Research, Vol. 41, Iss. 6, 2000-06 ,pp. : 605-612

Academic Press

Access to resources Recommend Favorite